Education Information

This activity is supported by educational grants from commercial interests. Complete information will be provided to participants prior to the activity. Educational credit will be available to attendees.

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

Practicing Allergists/Immunologists
Academic Allergists including Training Program and Division Directors
Allergy/Immunology Fellows-in-Training
Physician Assistants and Advanced Practice Nurses
Allied Health Professionals
Practice Management/Office Administrators
Primary Care Physicians and other medical professionals

Overall Educational Objectives

At the conclusion of this activity, participants should be able to:

Identify major advances in key areas of cutting-edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of the upper airways, lungs, eyes, skin, and gastrointestinal tract.
Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency.
Translate emerging clinical science principles to clinical practice in patients with allergic and immunologic diseases.
Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergic and immunologic diseases.
Explain the impact of environmental exposures and external influences on patients with allergic disorders.
Recognize emerging trends in the prevalence of allergic and immunologic disorders and discuss their impact on public health.
Evaluate the impact of new diagnostic and therapeutic strategies on health care costs and outcomes.
Discuss processes, tools and technologies for an efficient allergy and immunology practice.

Disclosure Statement

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, the College must identify and mitigate conflicts of interest for all individuals responsible for the development, management, presentation, and/or evaluation relevant to a CME activity. Disclosed information is reviewed in advance to manage and mitigate any potential conflicts of interest. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. All relevant financial relationships have been mitigated.

Accreditation Statements

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP 17239.

Credit Designation

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 28.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP 17239.and this activity has been designated for up to 28.75 Continuing Education contact hours.

This continuing medical education activity has been reviewed by the American Academy of Pediatrics (AAP) and is acceptable for a maximum of 28.75 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

Advanced Practice Health Care Providers
One-Day Course:
This activity has been designated for up to 7.5 Continuing Education contact hours.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Allied Health Professionals
One-Day Course:
This activity has been designated for up to 6.0 Continuing Education contact hours.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

ACAAI will not be designating any 2025 Annual Meeting sessions for MOC Part II Self-Assessment Credit. However, you’ll find other opportunities to earn MOC Part II Self-Assessment credit on the College Learning Connection (education.acaai.org).

IMPORTANT: ABAI’s MOC program requires Diplomates to obtain a minimum of 25 CME credits in allergy and immunology each year. CME credits for the Annual Meeting can be applied to this requirement.